Biotech

All Articles

Gene publisher Volume laying off 131 employees

.Merely times after genetics editor Tome Biosciences declared unrevealed working slices, a more clea...

Repare lays off 25% of personnel as biotech standstills preclinical R&ampD

.Repare Therapy is laying off an one-fourth of its labor force as the oncology biotech scales back i...

J &amp J declare FDA approval of $6.5 B autoimmune drug

.Johnson &amp Johnson has gotten another step towards understanding a gain on its own $6.5 billion n...

Gain's stage 1 win paves way to verify Parkinson's medication's worth

.Gain Rehabs has established its own direct showing the efficiency of its own Parkinson's health con...

Actinogen documents brand new period 2 records to restore clinical depression drug

.Actinogen Medical's hopes-- and stock price-- have rebounded a little coming from previously this m...

Pfizer and Crown jewel include Quotient to multibillion-dollar equation

.Crown Jewel Pioneering as well as Pfizer have incorporated Ratio right into their 10-program partne...

Bayer pens $547M treaty to press perimeters of noncoding RNA

.Bayer execs were actually interested to stress to Intense this summer season that the German pharma...

UK reveals strategies to release 18 brand new medical trial centers

.Surrounded by a yearslong medical trial decrease in the U.K., a brand new public-private alliance h...

UPDATE: Genentech telegraphs 93 unemployments in California after discussing plans to shutter cancer immunology research device

.Observing the statement of a big layoff shot in April as well as a significant rebuilding project r...

Neurocrine's KarXT competitor attacks in phase 2-- but only at reduced dosage

.Neurocrine Biosciences has attained its own hoped-for profile in a phase 2 mental illness test, del...